Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah

R R Williams1, P N Hopkins, S C Hunt

  • 1Department of Medicine, University of Utah, Salt Lake City.

Insights

Familial dyslipidemia syndromes are common in early coronary heart disease (CHD) families. Early recognition and treatment of lipid abnormalities like high cholesterol and low HDL-C are crucial for preventing premature CHD.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Metabolic Disorders

Background:

  • Early coronary heart disease (CHD) often has underlying genetic lipid disorders.
  • Familial dyslipidemia syndromes are frequently undiagnosed, contributing to premature cardiovascular events.

Purpose of the Study:

  • To determine the frequency of familial dyslipidemia syndromes in families with early-onset CHD.
  • To identify common lipid abnormalities and genetic syndromes associated with premature CHD.

Main Methods:

  • Blood lipid tests were conducted on 33 families with at least two siblings diagnosed with CHD before age 55.
  • Prevalence of specific lipid abnormalities (cholesterol, triglycerides, HDL-C) and familial syndromes was calculated.

Main Results:

  • Three-fourths of individuals with early CHD exhibited significant lipid abnormalities.
  • Familial combined hyperlipidemia and familial dyslipidemic hypertension were the most prevalent syndromes.
  • Abnormalities in high-density lipoprotein cholesterol (HDL-C) and triglycerides were more common than low-density lipoprotein cholesterol (LDL-C) issues.

Conclusions:

  • Common familial dyslipidemia syndromes are strongly associated with early-onset CHD.
  • Physicians must evaluate family history and all lipid parameters to identify and manage these conditions proactively.
  • Timely diagnosis and treatment of familial dyslipidemias can mitigate the risk of premature CHD.

Related Concept Videos

Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...